Inducible nitric oxide synthase, Nos2, does not mediate optic neuropathy and retinopathy in the DBA/2J glaucoma model.
about
Neuroprotection in GlaucomaInducible nitric oxide synthase-mediated alteration of mitochondrial OPA1 expression in ocular hypertensive ratsDifferential gene expression in glaucomaRegulation of nitric oxide production by δ-opioid receptors during glaucomatous injury.Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucomaα-Lipoic acid antioxidant treatment limits glaucoma-related retinal ganglion cell death and dysfunction.Rationale for the use of multifunctional drugs as neuroprotective agents for glaucoma.The Bcl-2 family member BIM has multiple glaucoma-relevant functions in DBA/2J miceMutant human myocilin induces strain specific differences in ocular hypertension and optic nerve damage in mice.Involvement of the CD200 receptor complex in microglia activation in experimental glaucoma.Friend or foe? Resolving the impact of glial responses in glaucomaLoss of Fractalkine Signaling Exacerbates Axon Transport Dysfunction in a Chronic Model of Glaucoma.Pathophysiology of human glaucomatous optic nerve damage: insights from rodent models of glaucoma.Autocrine and paracrine interactions and neuroprotection in glaucoma.A practical approach to optic nerve crush in the mouse.Delta Opioids: Neuroprotective Roles in Preclinical Studies.
P2860
Q26740388-5F01A6FF-19AE-494B-BB77-CC9D097189E8Q33789800-C16E7FC1-B389-4B8B-9418-1266FBB660ACQ33790678-FEAA94C3-F1FF-4FA1-903E-B1F7BF3B3D11Q34362259-D8C78B5C-E147-4485-A48E-458476B084CAQ34755301-20F26BAD-54B8-4363-813A-50EA03F36F08Q34766445-DF7FBD62-532B-4CAD-B6B2-93E7E0DF7EFEQ35157723-D003B598-AF09-4AB1-BB52-7CBD8C4642AAQ36114184-7ED4CFEB-A5C3-46B6-9207-FD38894F453EQ36730478-D15DDCB0-FE4A-4A23-8F64-B3ED87B02CB6Q36833382-CEE25BD0-509D-4498-B243-4ABA653CC9F0Q37230041-C171F7E8-1E52-413A-83A5-473C401EFBC2Q37440705-B17E4B95-149F-4347-919A-F0379AD74883Q37779827-299BC843-D1D3-4EBE-BCFB-049E572356DBQ38077464-4EA61F0B-3337-4C10-8C8D-EB7FCD223AC6Q42259751-925DE342-BD2F-471C-B03F-89E42FF70241Q49925827-07593BE8-191D-4F95-AC8B-28AB24929BAF
P2860
Inducible nitric oxide synthase, Nos2, does not mediate optic neuropathy and retinopathy in the DBA/2J glaucoma model.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Inducible nitric oxide synthas ...... in the DBA/2J glaucoma model.
@ast
Inducible nitric oxide synthas ...... in the DBA/2J glaucoma model.
@en
Inducible nitric oxide synthas ...... in the DBA/2J glaucoma model.
@nl
type
label
Inducible nitric oxide synthas ...... in the DBA/2J glaucoma model.
@ast
Inducible nitric oxide synthas ...... in the DBA/2J glaucoma model.
@en
Inducible nitric oxide synthas ...... in the DBA/2J glaucoma model.
@nl
prefLabel
Inducible nitric oxide synthas ...... in the DBA/2J glaucoma model.
@ast
Inducible nitric oxide synthas ...... in the DBA/2J glaucoma model.
@en
Inducible nitric oxide synthas ...... in the DBA/2J glaucoma model.
@nl
P2093
P2860
P356
P1433
P1476
Inducible nitric oxide synthas ...... in the DBA/2J glaucoma model.
@en
P2093
Abbot F Clark
Gareth R Howell
Iok-Hou Pang
Joseph W Barter
Olga V Savinova
Richard S Smith
Simon W M John
P2860
P2888
P356
10.1186/1471-2202-8-108
P577
2007-12-19T00:00:00Z
P5875
P6179
1013848613